CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in GLSI — Greenwich LifeSciences, Inc.

CIK 884546 SAN FRANCISCO, CA

Position in GLSI

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$398,804

-$1,247 QoQ

Shares Held

16,603

-12.8% QoQ

Ownership

0.113%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,185,699,337 across 288 Biotechnology names. GLSI ranks #228 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	1,920,871	$857,745,736
2	REGN	Regeneron Pharmaceuticals, Inc.	804,508	$621,595,061
3	MRNA	Moderna, Inc.	4,734,356	$240,505,284
4	ALNY	Alnylam Pharmaceuticals, Inc.	673,356	$222,793,299
5	INSM	INSMED Inc	1,069,390	$174,866,652
6	RVMD	Revolution Medicines, Inc.	1,735,476	$168,775,041
7	INCY	Incyte Corp	1,729,102	$162,743,080
8	BBIO	BridgeBio Pharma, Inc.	1,976,094	$146,744,740

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$398,804	16,603	-12.8%	Shares	Sole	2026-05-15
2025-12-31	$400,051	19,041	+0.2%	Shares	Sole	2026-02-13
2025-09-30	$189,069	19,002	-0.2%	Shares	Sole	2025-11-10
2025-06-30	$172,774	19,049	+0.2%	Shares	Sole	2025-08-12
2025-03-31	$181,326	19,007	+15.5%	Shares	Sole	2025-09-15
2024-12-31	$184,789	16,455	0.0%	Shares	Sole	2025-02-06
2024-09-30	$236,458	16,455	-10.8%	Shares	Sole	2024-11-12
2024-06-30	$318,516	18,454	+81.1%	Shares	Sole	2024-08-12
2022-03-31	$199,947	10,191	+3.8%	Shares	Sole	2022-05-13
2021-12-31	$238,896	9,819	0.0%	Shares	Sole	2022-02-11
2021-09-30	$383,628	9,819	0.0%	Shares	Sole	2021-11-16
2021-06-30	$441,265	9,819	—	Shares	Sole	2021-08-16
No filing history on record for this holder in this stock.